The USC Pharmaceutical Industry Fellowship Programs

USA
October 27, 2025

Job Overview

Job Description

The USC Pharmaceutical Industry Fellowship Programs are designed to prepare postdoctoral scholars for rewarding careers in the pharmaceutical and biopharmaceutical industry. Fellows work with mentors and engage in training activities that enhance the skills required to excel in their field. Professional development support is a cornerstone of the fellowship, with opportunities for individualized goal setting, strengths identification and assessments, advising, coaching and mentoring.

Training opportunities for doctoral candidates include clinical development, drug delivery, health economics and outcomes research, medical and regulatory affairs, pharmacology, oncology, patient safety and more.

Upon completion of the program, fellows are well-prepared for the challenges of a career in the pharmaceutical industry. Alumni have gone on to secure impactful roles across industry, pharmacy practice, and research.

Key Highlights

  • Access to USC regulatory sciences, biopharmaceutical marketing and healthcare decision analysis courses and tuition remission, up to four units per semester towards a graduate certificate
  • Networking with USC faculty, student fellows, and alumni
  • Professional development support through individualized goal setting, strengths identification/assessments, advising, coaching, and mentoring opportunities
  • Financial relocation assistance for fellows
  • Financial support to attend professional conferences and events
  • Possible teaching opportunities for APPE students 

Available Fellowships

Please refer to the brochures below for details on the specific programs offered with our industry partners. Each fellowship provides unique opportunities for trainees to build specialized expertise for their chosen career path.

Fellowships are offered as one-year or two-year programs, beginning July 1 and ending June 30. While most programs follow this schedule, start and end dates are subject to change.

AbbVie Inc.

Bausch + Lomb

Gilead Sciences Inc.

MannKind Corporation

Neurocrine Biosciences

Revolution Medicines